News
A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...
Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...
Rise and shine, another busy — and really hot — day is on the way. We can tell because the official mascots are spending less time on the dusty Pharmalot grounds and, instead, have ...
Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes are wafting across the Pharmalot campus, a welcome change after the unusually steamy heat of the past few ...
Several pharma companies lose out in a ruling that prevents them making generic oxycodone over fears of misuse. In a controversial decision that hands a victory to Purdue Pharma, the US Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results